|
|
The Auditorium : OFFICIAL WELCOME & LARGE CLINICAL TRIALS
|
10:30
|
OPENING SPEECHES
|
|
|
|
|
10:45
|
A RANDOMIZED TRIAL OF UNRUPTURED BRAIN AVMS (ARUBA): FINAL OUTCOME RESULTS BY TREATMENT MODALITY
C. Stapf, Canada
|
|
|
|
|
10:55
|
CLOT LYSIS: EVALUATING ACCELERATED RESOLUTION OF INTRAVENTRICULAR HEMORRHAGE (CLEAR III) 365-DAY RESULTS
K. Lane, USA
|
|
|
|
|
11:25
|
ULTRASOUND ENHANCED THROMBOLYSIS FOR ISCHEMIC STROKE: RESULTS OF A MULTI-NATIONAL PHASE III TRIAL (CLOTBUSTER)
Andrei V. Alexandrov, USA
|
|
|
|
|
11:35
|
ENCHANTED MAIN RESULTS - TRIAL OF LOW-DOSE VERSUS STANDARD-DOSE INTRAVENOUS TISSUE PLASMINOGEN ACTIVATOR IN 3310 PATIENTS WITH ACUTE ISCHEMIC STROKE
Craig Anderson, Australia
|
|
|
|
|
11:40
|
EFFICACY OF LOW-DOSE VS STANDARD-DOSE RTPA BETWEEN ASIAN AND NON-ASIAN WITH PARTICULAR EMPHASIS ON STROKE SUBTYPE AND RISK OF INTRACEREBRAL HEMORRHAGE
John Chalmers, Australia
|
|
|
|
|
11:45
|
BENEFITS AND RISKS OF LOW- VERSUS STANDARD-DOSE ALTEPLASE IN PATIENTS ON PRIOR ANTIPLATELET THERAPY: THE ENCHANTED TRIAL
T. Robinson, United Kingdom
|
|
|
|
|
11:55
|
TICAGRELOR VS. ASPIRIN IN ACUTE STROKE OR TRANSIENT ISCHEMIC ATTACK: PRIMARY RESULTS OF THE SOCRATES RANDOMIZED TRIAL
S.C. Johnston, USA
|
|
|
|
The Auditorium : PRESIDENTS' SYMPOSIUM: AWARDS AND TRIALS
|
14:15
|
AWARDS
|
|
|
|
|
14:35
|
FACTOR XA INHIBITORS VERSUS VITAMIN K ANTAGONISTS FOR PREVENTING CEREBRAL OR SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: RESULTS FROM AN UPDATED COCHRANE SYSTEMATIC REVIEW
E. Borge, Norway
|
|
|
|
|
15:05
|
THE VERTEBRAL ARTERY ISCHAEMIA STENTING TRIAL (VIST) - FIRST RESULTS ON BEHALF OF THE VIST INVESTIGATORS
H. Markus, United Kingdom
|
|
|
|
|
15:25
|
EFFECTS OF ALTEPLASE WITHIN 6 HOURS OF ISCHAEMIC STROKE ON SURVIVAL UP TO 3 YEARS: RESULTS FROM THE THIRD INTERNATIONAL STROKE TRIAL
E. Berge, Norway
|
|
|
|
|
15:35
|
PLATELET TRANSFUSION IN CEREBRAL HAEMORRHAGE (PATCH): A RANDOMISED CONTROLLED CLINICAL TRIAL
Yvo Roos, Netherlands
|
|
|